Starting April 5, patients can read your notes: 5 things to considerApril 1, 2021Practice ManagementPatient & Survivor CareMixed Topics
Delirium risk factors identified in ICU cancer patientsMarch 31, 2021Critical CarePatient & Survivor CareOncology
Paving the way for diversity in clinical trialsMarch 25, 2021Diversity in MedicinePatient & Survivor Care
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareBreast CancerGastrointestinal CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple Myeloma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
JAMA editor resigns over controversial podcastMarch 11, 2021Diversity in MedicinePatient & Survivor CareMixed Topics
JAMA podcast on racism in medicine faces backlashMarch 5, 2021Diversity in MedicinePatient & Survivor CarePractice ManagementMixed Topics
New ASH guidelines: VTE prevention and treatment in cancer patientsMarch 2, 2021ThrombosisPreventive CarePatient & Survivor CareVenous ThromboembolismHematologyOncology
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021COVID-19 UpdatesTransplantPatient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary Cancer
Model predicts acute kidney injury in cancer patients a month in advanceFebruary 1, 2021Patient & Survivor CareGenitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersGynecologic CancerLung CancerGastrointestinal Cancer
Medicaid to cover routine costs for patients in trialsJanuary 4, 2021Practice ManagementPatient & Survivor CareMixed Topics
COVID-19 vaccines and cancer patients: 4 things to knowDecember 21, 2020Patient & Survivor CareCOVID-19 UpdatesCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantMultiple MyelomaMyelodysplastic Syndrome
‘Practice changing’: Ruxolitinib as second-line in chronic GVHDDecember 8, 2020TransplantPatient & Survivor Care
No benefit from tranexamic acid prophylaxis in blood cancersDecember 7, 2020ThrombosisPatient & Survivor CareBleeding Disorders